Compare Flagstar Bank NA (FLG) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flagstar Bank NA vs Kymera Therapeutics Inc. Common Stock — how do they compare? Flagstar Bank NA trades at $11.07 (market cap $4.61B), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Flagstar Bank NA pays a 0.36% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flagstar Bank NA for 23 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FLG | KYMR | |
|---|---|---|
Market Cap | $4.61B | $8.88B |
Volume | 4,112,400 | 1,028,790 |
Sector | Financials | Health |
52-Week High | $15.36 | $127.31 |
52-Week Low | $10.72 | $55.80 |
Typical Hold Time | 23 Days | 0 Days |
Enterprise Value | $15.13B | $8.27B |
Dividend Yield | 0.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Flagstar Bank (FLG) trades at $11.21, down 0.88% today, with a bearish technical outlook despite positive analyst sentiment. The stock shows mixed fundamentals with a low P/B ratio of 0.6x but elevated P/E of 370x due to recent profitability challenges. Recent Q2 2026 earnings missed expectations, though the company announced a $250 million share repurchase program and maintains a dividend. Cash flow trends improved in 2026 with positive operating cash flow of $162 million versus negative $181 million in 2025.
The investment case balances analyst optimism (60% buy ratings, $16.81 consensus target) against weak technicals and earnings volatility. Key opportunities include the discounted valuation relative to book value and strategic initiatives like the Fiserv partnership. Risks include inconsistent earnings performance, high interest expense ($2.75B in 2025), and bearish momentum indicators. The stock presents a value opportunity if operational improvements continue.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
